Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimi HealthOPTH -0.10%19 PB Ratio is 2.24 as of Aug. 30, 2026, which is 11% above its 10-year median of 2.01. GuruFocus rates OPTH with a GF Score™ of 19/100 and a GF Value™ of $2.47 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 921 Drug Manufacturers companies, Optimi Health ranks worse than 54.72% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-30), Optimi Health's share price is $4.91. Optimi Health's Book Value per Share for the quarter that ended in Jun. 2026 was $2.20. Hence, Optimi Health's PB Ratio of today is 2.24.
Good Sign:
Optimi Health Corp stock PB Ratio (=2.22) is close to 1-year low of 2.11.
The historical rank and industry rank for Optimi Health's PB Ratio or its related term are showing as below:
OPTH'
s PB Ratio Range Over the Past 10 Years
Min: 0.9 Med: 2.01 Max: 9.85
Current: 2.22
During the past 6 years, Optimi Health's highest PB Ratio was 9.85. The lowest was 0.90. And the median was 2.01.
OPTH's PB Ratio is ranked worse than 54.72% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.98
vs OPTH: 2.22
During the past 12 months, Optimi Health's average Book Value Per Share Growth Rate was 28.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -30.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -11.20% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Optimi Health was 25.40% per year. The lowest was -30.50% per year. And the median was -30.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Optimi Health PB Ratio Related Terms
Optimi Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Optimi Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimi Health PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Optimi Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Optimi Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Optimi Health's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Optimi Health (OPTH) has a PB Ratio of 2.24 as of Aug. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Optimi Health and its competitors. This is 11% above median its historical median of 2.01. Over the past decade, Optimi Health's PB Ratio has ranged from 0.90 to 9.85. According to the industry distribution chart, Optimi Health ranks #504 out of 921 companies in the Drug Manufacturers industry, placing it in the top 54.7%.
Is Optimi Health's PB Ratio too high?
Optimi Health's current PB Ratio of 2.24 is 11% above median its 10-year median of 2.01. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 9.85. The Drug Manufacturers industry median PB Ratio is 1.98. Optimi Health's value of 2.24 is 13.1% above this industry median. Based on the distribution chart, Optimi Health ranks #504 out of 921 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Optimi Health has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #504 out of 921 companies for PB Ratio. This places Optimi Health in the lower half of its industry. The industry median PB Ratio is 1.98. Optimi Health's value of 2.24 is 13.1% above this benchmark. Historically, Optimi Health's own PB Ratio has ranged from 0.90 to 9.85 over the past decade. While the company's 10-year median is 2.01 vs. the industry median of 1.98, Optimi Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.98, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optimi Health's current PB Ratio of 2.24 is 13.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Optimi Health and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimi Health's current PB Ratio is 2.24, which is 11% above median its own 10-year median of 2.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Based on GuruFocus' analysis, Optimi Health (OPTH) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.47, compared to a current price of $4.91 — trading 98.8% above its estimated fair value. The current PB Ratio is 2.24, which is 11% above median its 10-year median of 2.01 and 13.1% above the Drug Manufacturers industry median of 1.98. Optimi Health's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Optimi Health (OPTH), the current PB Ratio is 2.24 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimi Health (OPTH) Overvalued in 2026?
Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued.
The current stock price of $4.91 is trading 98.8% above its estimated GF Value™ of $2.47.
GuruFocus considers Optimi Health to be Significantly Overvalued.
Key valuation signals for OPTH:
PB Ratio: 2.24 (11% above median its 10-year median of 2.01)
GF Value™: $2.47 vs. price of $4.91 (98.8% above fair value)
Industry Position: 13.1% above the Drug Manufacturers median (#504 of 921)
No single metric tells the full story. See the OPTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
19GF Score
Get the complete analysis for OPTH
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPTH has been successfully added to your 
